
Dr. Joan Mannick—mTOR's Role in Aging
Longevity by Design
00:00
Is There a Best Model Organism for Rapamycin?
Matt Cabraline: The most studied model organism is not a model organism, it's humans. Is there a certain time throughout life when it makes the most sense to treat with rapamycin? He says where we really start seeing benefit is 75 and above. And now there's getting to be new data that Matt Cabraline is generating in aging dogs as well.
Transcript
Play full episode